{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:59:35Z","timestamp":1773251975797,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.030","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T15:50:12Z","timestamp":1718725812000},"page":"126063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A phase 3 non-inferiority trial of locally manufactured Meningococcal ACWY vaccine \u2018Ingovax ACWY\u2019 among Bangladeshi adults"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6774-6104","authenticated-orcid":false,"given":"Tasnuva","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imam","family":"Tauheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahinur","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golam","family":"Sarower Bhuyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-6706","authenticated-orcid":false,"given":"Rajib","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md","family":"Tarikul Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-5488","authenticated-orcid":false,"given":"Shaumik","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Amir Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Ahmmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Muktadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasneen","family":"Muktadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faez","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahbubul","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex S.","family":"Panday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanni","family":"Kundu Tanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Muktadir Rahman Ashik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md","family":"Rahad Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaikh","family":"Shariful Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raziuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Masudur Rahman Mia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samnun","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mainul Ahasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahima","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taufiqur","family":"Rahman Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohiul","family":"Islam Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-9888","authenticated-orcid":false,"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.030_b0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.38968.683958.AE","article-title":"Meningococcal disease and its management in children","volume":"333","author":"Hart","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.06.030_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40121-019-00262-9","article-title":"Incidence and prevention of invasive meningococcal disease in global mass gathering events","volume":"8","author":"Muttalif","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.06.030_b0015","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.030_b0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2334-12-310","article-title":"An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0025","unstructured":"World Meningitis Day | International Alliance of Patients\u2019 Organizations, (n.d.). https:\/\/www.iapo.org.uk\/events\/world-meningitis-day (accessed September 13, 2020)."},{"key":"10.1016\/j.vaccine.2024.06.030_b0030","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","article-title":"Deciphering the burden of meningococcal disease: conventional and under-recognized elements","volume":"59","author":"Martin\u00f3n-Torres","year":"2016","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2024.06.030_b0035","unstructured":"Hamborsky J, Kroger A, Wolfe C, Pinkbook | Home | Epidemiology of Vaccine Preventable Diseases | CDC, (2019). https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/index.html (accessed August 6, 2020)."},{"key":"10.1016\/j.vaccine.2024.06.030_b0040","unstructured":"WHO | Meningococcal meningitis, WHO (2018). http:\/\/www.who.int\/immunization\/diseases\/meningitis\/en\/ (accessed August 6, 2020)."},{"key":"10.1016\/j.vaccine.2024.06.030_b0045","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.06.030_b0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/S0950268811000574","article-title":"Meningococcal disease in Asia: an under-recognized public health burden","volume":"139","author":"Vyse","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.06.030_b0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21645515.2018.1532248","article-title":"Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies","volume":"15","author":"Booy","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2024.06.030_b0060","first-page":"006","article-title":"Global review of meningococcal disease. A shifting etiology","volume":"1","author":"Leimkugel","year":"2009","journal-title":"Afr J Bacteriol Res"},{"key":"10.1016\/j.vaccine.2024.06.030_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40121-016-0107-0","article-title":"Meningococcal vaccinations","volume":"5","author":"Crum-Cianflone","year":"2016","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.06.030_b0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jinf.2009.06.001","article-title":"Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region","volume":"59","author":"Abad","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2024.06.030_b0075","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3201\/eid2204.150653","article-title":"Neisseria meningitidis Serogroup X in Sub-Saharan Africa","volume":"22","author":"Agnememel","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(11)70337-1","article-title":"Emergence of medicine for mass gatherings: lessons from the Hajj","volume":"12","author":"Memish","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/367858","article-title":"Hajj-Associated Outbreak Strain of Neisseria meningitidis Serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers","volume":"36","author":"Wilder-Smith","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/323403","article-title":"Meningococcal disease and travel","volume":"34","author":"Memish","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijid.2016.04.007","article-title":"Meningococcal disease during the Hajj and Umrah mass gatherings","volume":"47","author":"Yezli","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0100","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/21645515.2018.1451810","article-title":"Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development","volume":"14","author":"Dretler","year":"2018","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2024.06.030_b0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4161\/hv.27739","article-title":"Review of meningococcal vaccines with updates on immunization in adults","volume":"10","author":"Zahlanie","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2024.06.030_b0110","first-page":"127","article-title":"Meningococcal vaccine for hajj pilgrims: compliance, predictors, and barriers","volume":"4","author":"Badahdah","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.030_b0115","unstructured":"Meningococcal vaccines, (n.d.). https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccines-quality\/meningococcal-vaccines (accessed March 17, 2024)."},{"key":"10.1016\/j.vaccine.2024.06.030_b0120","unstructured":"Quadri Meningo Package Insert, (n.d.). http:\/\/www.biomed.co.in\/wp-content\/uploads\/2017\/12\/Quadri-Meningo-as-per-WHO-TRS.pdf (accessed August 6, 2020)."},{"key":"10.1016\/j.vaccine.2024.06.030_b0125","unstructured":"C. for B.E. and Research, Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials, US Food Drug Adm. (2019). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical (accessed May 18, 2020)."},{"key":"10.1016\/j.vaccine.2024.06.030_b0130","unstructured":"Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, (n.d.). https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/table-for-grading-severity-of-adult-pediatric-adverse-events.pdf."},{"key":"10.1016\/j.vaccine.2024.06.030_b0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(22)00028-7","article-title":"COVID-19 vaccine inequity, dependency, and production capability in low-income and middle-income countries: the case of Bangladesh","volume":"22","author":"Mahmud-Al-Rafat","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2024.06.030_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.871670","article-title":"Sex-related differences in the immune response to meningococcal vaccinations during adolescence","volume":"10","author":"Ohm","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2024.06.030_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.vaccine.2024.06.030_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2008.08.075","article-title":"Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15\u201325 years","volume":"27","author":"\u00d8stergaard","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.030_b0155","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ebch.753","article-title":"Cochrane review: polysaccharide vaccines for preventing serogroup A meningococcal meningitis","volume":"6","author":"Patel","year":"2011","journal-title":"Evid-Based Child Health Cochrane Rev J"},{"key":"10.1016\/j.vaccine.2024.06.030_b0160","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0929-6646(09)60371-5","article-title":"Safety and immunogenicity of a tetravalent polysaccharide vaccine against meningococcal disease","volume":"108","author":"Shao","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2024.06.030_b0165","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1186\/1471-2458-11-S3-S29","article-title":"An evaluation of emerging vaccines for childhood meningococcal disease","volume":"11","author":"Choudhuri","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2024.06.030_b0170","first-page":"20","article-title":"Bangladeshi migration across the globe: the recent experiences of developmentand challenge","volume":"6","author":"Al Masud","year":"2019","journal-title":"Int J Res Humanit Soc Stud"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:42:58Z","timestamp":1773182578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24007047"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 3 non-inferiority trial of locally manufactured Meningococcal ACWY vaccine \u2018Ingovax ACWY\u2019 among Bangladeshi adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126063"}}